Jules Mugabo

High Levels of Adherence and Viral Suppression in a Nationally Representative Sample of HIV-Infected Adults on Antiretroviral Therapy for 6, 12 and 18 Months in Rwanda

Batya Elul, Paulin Basinga, Harriet Nuwagaba‐Biribonwoha et al. · PLoS ONE · 2013 · 88 citations · Full text

Adult Clinical and Immunologic Outcomes of the National Antiretroviral Treatment Program in Rwanda During 2004-2005

David Lowrance, François Ndamage, Eugenie Kayirangwa et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2009 · 61 citations

Stavudine- and nevirapine-related drug toxicity while on generic fixed-dose antiretroviral treatment: incidence, timing and risk factors in a three-year cohort in Kigali, Rwanda

Johan van Griensven, Rony Zachariah, Freya Rasschaert et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene · 2009 · 54 citations

Three-year Cohort, Pharmacotherapy, Antiviral Drug +17

Drug resistance mutations after the first 12 months on antiretroviral therapy and determinants of virological failure in Rwanda

Jean d’Amour Ndahimana, David J. Riedel, Mwumvaneza Mutagoma et al. · Tropical Medicine & International Health · 2016 · 50 citations · Full text

Exceptional genetic variability of hepatitis B virus indicates that Rwanda is east of an emerging African genotype E/A1 divide

Judith M. Hübschen, Jules Mugabo, Cécile Peltier et al. · Journal of Medical Virology · 2009 · 42 citations · Full text